Connect Biopharma Holdings (Connect Biopharma Holdings) Change In Payables And Accrued Expense : $-4.75 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Change In Payables And Accrued Expense?

Connect Biopharma Holdings's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $-4.51 Mil. It means Connect Biopharma Holdings's Accounts Payable & Accrued Expense declined by $4.51 Mil from Jun. 2023 to Dec. 2023 .

Connect Biopharma Holdings's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $-4.75 Mil. It means Connect Biopharma Holdings's Accounts Payable & Accrued Expense declined by $4.75 Mil from Dec. 2022 to Dec. 2023 .

Connect Biopharma Holdings Change In Payables And Accrued Expense Historical Data

The historical data trend for Connect Biopharma Holdings's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Change In Payables And Accrued Expense Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

3.01

1.59

7.24

-0.29

-4.75

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial				1.15	3.67	-3.96	-0.24	-4.51

Connect Biopharma Holdings Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-4.75 Mil.

Connect Biopharma Holdings Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings (Connect Biopharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.